The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine

Summary Eleven patients with distal subungal onychomycosis of the fingers by Trichophyton rubrum infection were treated with daily doses of oral terbinafine, a new allylamine derivative. A 125‐mg capsule was given twice daily. Each patient's nailplate was marked appropriately following the Zaia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental dermatology 1989-03, Vol.14 (2), p.120-123
Hauptverfasser: ZAIAS, N., SERRANO, L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 123
container_issue 2
container_start_page 120
container_title Clinical and experimental dermatology
container_volume 14
creator ZAIAS, N.
SERRANO, L.
description Summary Eleven patients with distal subungal onychomycosis of the fingers by Trichophyton rubrum infection were treated with daily doses of oral terbinafine, a new allylamine derivative. A 125‐mg capsule was given twice daily. Each patient's nailplate was marked appropriately following the Zaias and Drachman method for the determination of antifungal efficacy in onychomycosis.1 Patients were monitored monthly for the antifungal effect of the drug, as well as side‐effects, including laboratory values for liver and kidney function tests and a full blood count. At the end of 6 months, all 11 patients were clinically and mycologically normal. It can be concluded that 250 mg (125 mg b.i.d.) oral terbinafine is the most appropriate drug for the treatment of finger onychomycosis. No side‐effects of any kind were noted in this 6‐month period.
doi_str_mv 10.1111/j.1365-2230.1989.tb00907.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79389399</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79389399</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4070-46009beef55781f6c655c36b2d5c17561fb28b544164fee09d87a939059bfc2d3</originalsourceid><addsrcrecordid>eNqVkE1v0zAYxy3ENMrGR0CyOHBLZ8exHXNAYmVsExPsUATiYsXuY-qSxMVOtObbz1Wr3vHF0vN_8eMfQu8omdN8rjZzygQvypLlgarVfDCEKCLnuxdodpJeohlhRBZCsfoVep3ShhDKqOTn6LzkrCR1NUO_l2vAabQWUnJji4cIzdBBP-DgsPP9H4h4Gb1dh-16GkKP42ji2OHQT3nWTTYkn_CTH9Y4xCbnIRrfNzkJl-jMNW2CN8f7Av34crNc3BUP32_vF58eClsRSYpK5N0NgONc1tQJKzi3TJhyxW1eVlBnytrwqqKicgBErWrZKKYIV8bZcsUu0PtD7zaGfyOkQXc-WWjbpocwJi3z_7NfZeOHg9HGkFIEp7fRd02cNCV6D1Zv9J6e3tPTe7D6CFbvcvjt8ZXRdLA6RY8ks_7xoD_5Fqb_aNaLm8-0JLmgOBT4NMDuVNDEv1pIJrn--e1W8zvKyPXXX_qRPQO7IZi_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79389399</pqid></control><display><type>article</type><title>The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>ZAIAS, N. ; SERRANO, L.</creator><creatorcontrib>ZAIAS, N. ; SERRANO, L.</creatorcontrib><description>Summary Eleven patients with distal subungal onychomycosis of the fingers by Trichophyton rubrum infection were treated with daily doses of oral terbinafine, a new allylamine derivative. A 125‐mg capsule was given twice daily. Each patient's nailplate was marked appropriately following the Zaias and Drachman method for the determination of antifungal efficacy in onychomycosis.1 Patients were monitored monthly for the antifungal effect of the drug, as well as side‐effects, including laboratory values for liver and kidney function tests and a full blood count. At the end of 6 months, all 11 patients were clinically and mycologically normal. It can be concluded that 250 mg (125 mg b.i.d.) oral terbinafine is the most appropriate drug for the treatment of finger onychomycosis. No side‐effects of any kind were noted in this 6‐month period.</description><identifier>ISSN: 0307-6938</identifier><identifier>EISSN: 1365-2230</identifier><identifier>DOI: 10.1111/j.1365-2230.1989.tb00907.x</identifier><identifier>PMID: 2532084</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Administration, Oral ; Antifungal Agents - administration &amp; dosage ; Hand Dermatoses - drug therapy ; Humans ; Male ; Naphthalenes - administration &amp; dosage ; Onychomycosis - drug therapy ; Terbinafine ; Trichophyton</subject><ispartof>Clinical and experimental dermatology, 1989-03, Vol.14 (2), p.120-123</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4070-46009beef55781f6c655c36b2d5c17561fb28b544164fee09d87a939059bfc2d3</citedby><cites>FETCH-LOGICAL-c4070-46009beef55781f6c655c36b2d5c17561fb28b544164fee09d87a939059bfc2d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2532084$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ZAIAS, N.</creatorcontrib><creatorcontrib>SERRANO, L.</creatorcontrib><title>The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine</title><title>Clinical and experimental dermatology</title><addtitle>Clin Exp Dermatol</addtitle><description>Summary Eleven patients with distal subungal onychomycosis of the fingers by Trichophyton rubrum infection were treated with daily doses of oral terbinafine, a new allylamine derivative. A 125‐mg capsule was given twice daily. Each patient's nailplate was marked appropriately following the Zaias and Drachman method for the determination of antifungal efficacy in onychomycosis.1 Patients were monitored monthly for the antifungal effect of the drug, as well as side‐effects, including laboratory values for liver and kidney function tests and a full blood count. At the end of 6 months, all 11 patients were clinically and mycologically normal. It can be concluded that 250 mg (125 mg b.i.d.) oral terbinafine is the most appropriate drug for the treatment of finger onychomycosis. No side‐effects of any kind were noted in this 6‐month period.</description><subject>Administration, Oral</subject><subject>Antifungal Agents - administration &amp; dosage</subject><subject>Hand Dermatoses - drug therapy</subject><subject>Humans</subject><subject>Male</subject><subject>Naphthalenes - administration &amp; dosage</subject><subject>Onychomycosis - drug therapy</subject><subject>Terbinafine</subject><subject>Trichophyton</subject><issn>0307-6938</issn><issn>1365-2230</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkE1v0zAYxy3ENMrGR0CyOHBLZ8exHXNAYmVsExPsUATiYsXuY-qSxMVOtObbz1Wr3vHF0vN_8eMfQu8omdN8rjZzygQvypLlgarVfDCEKCLnuxdodpJeohlhRBZCsfoVep3ShhDKqOTn6LzkrCR1NUO_l2vAabQWUnJji4cIzdBBP-DgsPP9H4h4Gb1dh-16GkKP42ji2OHQT3nWTTYkn_CTH9Y4xCbnIRrfNzkJl-jMNW2CN8f7Av34crNc3BUP32_vF58eClsRSYpK5N0NgONc1tQJKzi3TJhyxW1eVlBnytrwqqKicgBErWrZKKYIV8bZcsUu0PtD7zaGfyOkQXc-WWjbpocwJi3z_7NfZeOHg9HGkFIEp7fRd02cNCV6D1Zv9J6e3tPTe7D6CFbvcvjt8ZXRdLA6RY8ks_7xoD_5Fqb_aNaLm8-0JLmgOBT4NMDuVNDEv1pIJrn--e1W8zvKyPXXX_qRPQO7IZi_</recordid><startdate>198903</startdate><enddate>198903</enddate><creator>ZAIAS, N.</creator><creator>SERRANO, L.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198903</creationdate><title>The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine</title><author>ZAIAS, N. ; SERRANO, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4070-46009beef55781f6c655c36b2d5c17561fb28b544164fee09d87a939059bfc2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Administration, Oral</topic><topic>Antifungal Agents - administration &amp; dosage</topic><topic>Hand Dermatoses - drug therapy</topic><topic>Humans</topic><topic>Male</topic><topic>Naphthalenes - administration &amp; dosage</topic><topic>Onychomycosis - drug therapy</topic><topic>Terbinafine</topic><topic>Trichophyton</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ZAIAS, N.</creatorcontrib><creatorcontrib>SERRANO, L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ZAIAS, N.</au><au>SERRANO, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine</atitle><jtitle>Clinical and experimental dermatology</jtitle><addtitle>Clin Exp Dermatol</addtitle><date>1989-03</date><risdate>1989</risdate><volume>14</volume><issue>2</issue><spage>120</spage><epage>123</epage><pages>120-123</pages><issn>0307-6938</issn><eissn>1365-2230</eissn><abstract>Summary Eleven patients with distal subungal onychomycosis of the fingers by Trichophyton rubrum infection were treated with daily doses of oral terbinafine, a new allylamine derivative. A 125‐mg capsule was given twice daily. Each patient's nailplate was marked appropriately following the Zaias and Drachman method for the determination of antifungal efficacy in onychomycosis.1 Patients were monitored monthly for the antifungal effect of the drug, as well as side‐effects, including laboratory values for liver and kidney function tests and a full blood count. At the end of 6 months, all 11 patients were clinically and mycologically normal. It can be concluded that 250 mg (125 mg b.i.d.) oral terbinafine is the most appropriate drug for the treatment of finger onychomycosis. No side‐effects of any kind were noted in this 6‐month period.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>2532084</pmid><doi>10.1111/j.1365-2230.1989.tb00907.x</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0307-6938
ispartof Clinical and experimental dermatology, 1989-03, Vol.14 (2), p.120-123
issn 0307-6938
1365-2230
language eng
recordid cdi_proquest_miscellaneous_79389399
source MEDLINE; Alma/SFX Local Collection
subjects Administration, Oral
Antifungal Agents - administration & dosage
Hand Dermatoses - drug therapy
Humans
Male
Naphthalenes - administration & dosage
Onychomycosis - drug therapy
Terbinafine
Trichophyton
title The successful treatment of finger Trichophyton rubrum onychomycosis with oral terbinafine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T17%3A02%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20successful%20treatment%20of%20finger%20Trichophyton%20rubrum%20onychomycosis%20with%20oral%20terbinafine&rft.jtitle=Clinical%20and%20experimental%20dermatology&rft.au=ZAIAS,%20N.&rft.date=1989-03&rft.volume=14&rft.issue=2&rft.spage=120&rft.epage=123&rft.pages=120-123&rft.issn=0307-6938&rft.eissn=1365-2230&rft_id=info:doi/10.1111/j.1365-2230.1989.tb00907.x&rft_dat=%3Cproquest_cross%3E79389399%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79389399&rft_id=info:pmid/2532084&rfr_iscdi=true